Intelligence that heals.
Decode the airway, redefine the clinic, and scale precision sleep at NeuralPoint.
Contact UsPlatform pillars
Months to Minutes
An investigational point-of-care platform designed to evaluate physiologic patterns associated with obstructive sleep apnea — with the goal of enabling single-visit assessment.
Targets Root Cause
Investigating the underlying physiologic mechanisms of OSA — shifting focus from symptom measurement toward neuromuscular root-cause signals.
Precision Medicine
Objective physiologic measurements are being studied for their potential to inform future treatment approaches for individual patients.
Our Mission
NeuralPoint is a clinical-stage medical technology company developing the next generation of physiologic evaluation and clinical decision support for obstructive sleep apnea.
What is NeuralPoint technology
Continuous physiologic signatures linked to airway patency, neuromuscular activity, and sleep stage dynamics - designed to complement polysomnography and guide next-step care.
Total participants enrolled during clinical validation studies.
Investigational classification performance in identifying physiologic patterns associated with OSA.
Intra-category differentiation within the most clinically ambiguous OSA segment (AHI 5–15), based on early investigational data.
The Clinical Gap
OSA lacks physiologic clarity.
-
Current diagnostics measure symptoms Reactive monitoring focused on airflow cessation rather than neural drivers.
-
Event-based counting leaves clinicians without context AHI scores fail to capture the underlying neuromuscular collapse mechanism.
NeuralPoint's Answer
A structured neuromuscular intelligence layer.
-
Proprietary airway sensing technology Direct quantification of muscle recruitment via clinical-grade tmEMG™ sensors.
-
Objective, interpretable insight at the point of care Turning raw neurophysiological signals into structured physiologic biomarker outputs in minutes.
A new physiologic assessment layer in sleep medicine.
NeuralPoint introduces quantitative, continuous neuromuscular biomarkers into OSA evaluation — providing a novel physiologic signal layer to complement existing clinical assessment.
Physiology-first
Our tmEMG™ sensors capture high-fidelity neuromuscular signals directly from the airway muscles.
Patented HardwareClinician-facing Score
The EMGNet™ algorithm distills thousands of data points into a single, intuitive biomarker index.
EMGNet™ AI EngineDesigned for Validation
Built from the ground up for regulatory clearance, with data transparency and verification.
FDA Pathway ReadyResearch & Publications
The scientific foundation of NeuralPoint
Clinical Validation of tmEMG
Pilot study of a novel transmembranous EMG device - published in Muscle & Nerve, selected as the cover article.
Deep Learning Enhanced tmEMG in OSA Diagnosis
An investigational study demonstrated approximately 82% classification performance in identifying physiologic patterns associated with OSA (BMC Neuroscience); results are preliminary and require further validation.
OSA Neuromuscular Function White Paper
Co-authored by a KOL panel - demonstrates how NeuralPoint's technology could change the OSA diagnostic paradigm.